Position in IQV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,383,157
New position
Shares Held
60,884
first reported quarter
Ownership
0.036%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ARMISTICE CAPITAL, LLC holds $125,866,829 across 7 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
122,480 | $61,406,572 | |
| 2 | WAT |
Waters Corp /De/
|
75,004 | $28,129,500 | |
| 3 | ILMN |
Illumina, Inc.
|
91,118 | $16,021,277 | |
| 4 | TWST |
Twist Bioscience Corp
|
142,000 | $14,608,960 | |
| 5 | DHR |
Danaher Corp /De/
|
20,500 | $3,904,840 | |
| 6 | A |
Agilent Technologies, Inc.
|
11,982 | $1,591,569 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
900 | $204,111 |
All Filings in IQV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,383,157 | 60,884 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||